We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Review · December 23, 2020

Clinical and Pathological Characteristics of Patients With mRCC Needing Second-Line Therapy



Additional Info

Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review
Cancers (Basel) 2020 Dec 04;[EPub Ahead of Print], N Longo, M Capece, G Celentano, R La Rocca, G Califano, C Collà Ruvolo, C Buonerba, F Esposito, L Napolitano, F Mangiapia, F Fusco, V Mirone, M Creta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading